Global Acne Vulgaris Treatment Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 04-Mar-2020
No. of pages: 128
Inquire Before Buying

This report focuses on the global Acne Vulgaris Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acne Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Common Pharma Inc

- Cutanea Life Sciences Inc

- Dermira Inc

- ELORAC Inc

- Ensol Biosciences Inc

- Foamix Pharmaceuticals Ltd

- Galderma SA

- GlaxoSmithKline Plc

- Helix BioMedix Inc

- Hovione FarmaCiencia SA

- Lee's Pharmaceutical Holdings Ltd

- LEO Pharma A/S

- Novabiotics Ltd

- Novan Inc

- Novartis AG

- Paratek Pharmaceuticals Inc

- Pfizer Inc

- Phosphagenics Ltd

Market segment by Type, the product can be split into

- CB-0601

- CJM-112

- CLS-007

- Dapsone

- DFD-10

- DLX-2323

- Others

Market segment by Application, split into

- Clinic

- Hospital

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Acne Vulgaris Treatment status, future forecast, growth opportunity, key market and key players.

- To present the Acne Vulgaris Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acne Vulgaris Treatment are as follows:

- History Year: 2015-2019

- Base Year: 2019

- Estimated Year: 2020

- Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Acne Vulgaris Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acne Vulgaris Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CB-0601
1.4.3 CJM-112
1.4.4 CLS-007
1.4.5 Dapsone
1.4.6 DFD-10
1.4.7 DLX-2323
1.4.8 Others
1.5 Market by Application
1.5.1 Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Acne Vulgaris Treatment Market Perspective (2015-2026)
2.2 Acne Vulgaris Treatment Growth Trends by Regions
2.2.1 Acne Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Acne Vulgaris Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Acne Vulgaris Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Acne Vulgaris Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Treatment Players by Market Size
3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2015-2020)
3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acne Vulgaris Treatment Market Concentration Ratio
3.2.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2019
3.3 Acne Vulgaris Treatment Key Players Head office and Area Served
3.4 Key Players Acne Vulgaris Treatment Product Solution and Service
3.5 Date of Enter into Acne Vulgaris Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2021-2026)
5 Acne Vulgaris Treatment Breakdown Data by Application (2015-2026)
5.1 Global Acne Vulgaris Treatment Market Size by Application (2015-2020)
5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Acne Vulgaris Treatment Market Size (2015-2020)
6.2 Acne Vulgaris Treatment Key Players in North America (2019-2020)
6.3 North America Acne Vulgaris Treatment Market Size by Type (2015-2020)
6.4 North America Acne Vulgaris Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Acne Vulgaris Treatment Market Size (2015-2020)
7.2 Acne Vulgaris Treatment Key Players in Europe (2019-2020)
7.3 Europe Acne Vulgaris Treatment Market Size by Type (2015-2020)
7.4 Europe Acne Vulgaris Treatment Market Size by Application (2015-2020)
8 China
8.1 China Acne Vulgaris Treatment Market Size (2015-2020)
8.2 Acne Vulgaris Treatment Key Players in China (2019-2020)
8.3 China Acne Vulgaris Treatment Market Size by Type (2015-2020)
8.4 China Acne Vulgaris Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Acne Vulgaris Treatment Market Size (2015-2020)
9.2 Acne Vulgaris Treatment Key Players in Japan (2019-2020)
9.3 Japan Acne Vulgaris Treatment Market Size by Type (2015-2020)
9.4 Japan Acne Vulgaris Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Acne Vulgaris Treatment Market Size (2015-2020)
10.2 Acne Vulgaris Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020)
11 India
11.1 India Acne Vulgaris Treatment Market Size (2015-2020)
11.2 Acne Vulgaris Treatment Key Players in India (2019-2020)
11.3 India Acne Vulgaris Treatment Market Size by Type (2015-2020)
11.4 India Acne Vulgaris Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Acne Vulgaris Treatment Market Size (2015-2020)
12.2 Acne Vulgaris Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acne Vulgaris Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acne Vulgaris Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Common Pharma Inc
13.1.1 Common Pharma Inc Company Details
13.1.2 Common Pharma Inc Business Overview and Its Total Revenue
13.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
13.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020))
13.1.5 Common Pharma Inc Recent Development
13.2 Cutanea Life Sciences Inc
13.2.1 Cutanea Life Sciences Inc Company Details
13.2.2 Cutanea Life Sciences Inc Business Overview and Its Total Revenue
13.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
13.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.2.5 Cutanea Life Sciences Inc Recent Development
13.3 Dermira Inc
13.3.1 Dermira Inc Company Details
13.3.2 Dermira Inc Business Overview and Its Total Revenue
13.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
13.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.3.5 Dermira Inc Recent Development
13.4 ELORAC Inc
13.4.1 ELORAC Inc Company Details
13.4.2 ELORAC Inc Business Overview and Its Total Revenue
13.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
13.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.4.5 ELORAC Inc Recent Development
13.5 Ensol Biosciences Inc
13.5.1 Ensol Biosciences Inc Company Details
13.5.2 Ensol Biosciences Inc Business Overview and Its Total Revenue
13.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
13.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.5.5 Ensol Biosciences Inc Recent Development
13.6 Foamix Pharmaceuticals Ltd
13.6.1 Foamix Pharmaceuticals Ltd Company Details
13.6.2 Foamix Pharmaceuticals Ltd Business Overview and Its Total Revenue
13.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
13.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.6.5 Foamix Pharmaceuticals Ltd Recent Development
13.7 Galderma SA
13.7.1 Galderma SA Company Details
13.7.2 Galderma SA Business Overview and Its Total Revenue
13.7.3 Galderma SA Acne Vulgaris Treatment Introduction
13.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.7.5 Galderma SA Recent Development
13.8 GlaxoSmithKline Plc
13.8.1 GlaxoSmithKline Plc Company Details
13.8.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
13.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
13.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.8.5 GlaxoSmithKline Plc Recent Development
13.9 Helix BioMedix Inc
13.9.1 Helix BioMedix Inc Company Details
13.9.2 Helix BioMedix Inc Business Overview and Its Total Revenue
13.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
13.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.9.5 Helix BioMedix Inc Recent Development
13.10 Hovione FarmaCiencia SA
13.10.1 Hovione FarmaCiencia SA Company Details
13.10.2 Hovione FarmaCiencia SA Business Overview and Its Total Revenue
13.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
13.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
13.10.5 Hovione FarmaCiencia SA Recent Development
13.11 Lee's Pharmaceutical Holdings Ltd
10.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
10.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview and Its Total Revenue
10.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
10.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
13.12 LEO Pharma A/S
10.12.1 LEO Pharma A/S Company Details
10.12.2 LEO Pharma A/S Business Overview and Its Total Revenue
10.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
10.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.12.5 LEO Pharma A/S Recent Development
13.13 Novabiotics Ltd
10.13.1 Novabiotics Ltd Company Details
10.13.2 Novabiotics Ltd Business Overview and Its Total Revenue
10.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
10.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.13.5 Novabiotics Ltd Recent Development
13.14 Novan Inc
10.14.1 Novan Inc Company Details
10.14.2 Novan Inc Business Overview and Its Total Revenue
10.14.3 Novan Inc Acne Vulgaris Treatment Introduction
10.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.14.5 Novan Inc Recent Development
13.15 Novartis AG
10.15.1 Novartis AG Company Details
10.15.2 Novartis AG Business Overview and Its Total Revenue
10.15.3 Novartis AG Acne Vulgaris Treatment Introduction
10.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.15.5 Novartis AG Recent Development
13.16 Paratek Pharmaceuticals Inc
10.16.1 Paratek Pharmaceuticals Inc Company Details
10.16.2 Paratek Pharmaceuticals Inc Business Overview and Its Total Revenue
10.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
10.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.16.5 Paratek Pharmaceuticals Inc Recent Development
13.17 Pfizer Inc
10.17.1 Pfizer Inc Company Details
10.17.2 Pfizer Inc Business Overview and Its Total Revenue
10.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
10.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.17.5 Pfizer Inc Recent Development
13.18 Phosphagenics Ltd
10.18.1 Phosphagenics Ltd Company Details
10.18.2 Phosphagenics Ltd Business Overview and Its Total Revenue
10.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
10.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
10.18.5 Phosphagenics Ltd Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Acne Vulgaris Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acne Vulgaris Treatment Revenue
Table 3. Ranking of Global Top Acne Vulgaris Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acne Vulgaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CB-0601
Table 6. Key Players of CJM-112
Table 7. Key Players of CLS-007
Table 8. Key Players of Dapsone
Table 9. Key Players of DFD-10
Table 10. Key Players of DLX-2323
Table 11. Key Players of Others
Table 12. Global Acne Vulgaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Acne Vulgaris Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Acne Vulgaris Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Acne Vulgaris Treatment Market Share by Regions (2015-2020)
Table 16. Global Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Acne Vulgaris Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Acne Vulgaris Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Acne Vulgaris Treatment Players
Table 23. Global Acne Vulgaris Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Acne Vulgaris Treatment Market Share by Players (2015-2020)
Table 25. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2019)
Table 26. Global Acne Vulgaris Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Acne Vulgaris Treatment Product Solution and Service
Table 29. Date of Enter into Acne Vulgaris Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Acne Vulgaris Treatment Market Size Share by Type (2015-2020)
Table 33. Global Acne Vulgaris Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Acne Vulgaris Treatment Market Size Share by Application (2015-2020)
Table 35. Global Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Acne Vulgaris Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 39. North America Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 41. North America Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 45. Europe Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 47. Europe Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 51. China Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 53. China Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 57. Japan Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 59. Japan Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 63. Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 69. India Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 71. India Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Acne Vulgaris Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Acne Vulgaris Treatment Market Share (2019-2020)
Table 75. Central & South America Acne Vulgaris Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Acne Vulgaris Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Acne Vulgaris Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Acne Vulgaris Treatment Market Share by Application (2015-2020)
Table 79. Common Pharma Inc Company Details
Table 80. Common Pharma Inc Business Overview
Table 81. Common Pharma Inc Product
Table 82. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 83. Common Pharma Inc Recent Development
Table 84. Cutanea Life Sciences Inc Company Details
Table 85. Cutanea Life Sciences Inc Business Overview
Table 86. Cutanea Life Sciences Inc Product
Table 87. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 88. Cutanea Life Sciences Inc Recent Development
Table 89. Dermira Inc Company Details
Table 90. Dermira Inc Business Overview
Table 91. Dermira Inc Product
Table 92. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 93. Dermira Inc Recent Development
Table 94. ELORAC Inc Company Details
Table 95. ELORAC Inc Business Overview
Table 96. ELORAC Inc Product
Table 97. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 98. ELORAC Inc Recent Development
Table 99. Ensol Biosciences Inc Company Details
Table 100. Ensol Biosciences Inc Business Overview
Table 101. Ensol Biosciences Inc Product
Table 102. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 103. Ensol Biosciences Inc Recent Development
Table 104. Foamix Pharmaceuticals Ltd Company Details
Table 105. Foamix Pharmaceuticals Ltd Business Overview
Table 106. Foamix Pharmaceuticals Ltd Product
Table 107. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 108. Foamix Pharmaceuticals Ltd Recent Development
Table 109. Galderma SA Company Details
Table 110. Galderma SA Business Overview
Table 111. Galderma SA Product
Table 112. Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 113. Galderma SA Recent Development
Table 114. GlaxoSmithKline Plc Business Overview
Table 115. GlaxoSmithKline Plc Product
Table 116. GlaxoSmithKline Plc Company Details
Table 117. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 118. GlaxoSmithKline Plc Recent Development
Table 119. Helix BioMedix Inc Company Details
Table 120. Helix BioMedix Inc Business Overview
Table 121. Helix BioMedix Inc Product
Table 122. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 123. Helix BioMedix Inc Recent Development
Table 124. Hovione FarmaCiencia SA Company Details
Table 125. Hovione FarmaCiencia SA Business Overview
Table 126. Hovione FarmaCiencia SA Product
Table 127. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 128. Hovione FarmaCiencia SA Recent Development
Table 129. Lee's Pharmaceutical Holdings Ltd Company Details
Table 130. Lee's Pharmaceutical Holdings Ltd Business Overview
Table 131. Lee's Pharmaceutical Holdings Ltd Product
Table 132. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 133. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 134. LEO Pharma A/S Company Details
Table 135. LEO Pharma A/S Business Overview
Table 136. LEO Pharma A/S Product
Table 137. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 138. LEO Pharma A/S Recent Development
Table 139. Novabiotics Ltd Company Details
Table 140. Novabiotics Ltd Business Overview
Table 141. Novabiotics Ltd Product
Table 142. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 143. Novabiotics Ltd Recent Development
Table 144. Novan Inc Company Details
Table 145. Novan Inc Business Overview
Table 146. Novan Inc Product
Table 147. Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 148. Novan Inc Recent Development
Table 149. Novartis AG Company Details
Table 150. Novartis AG Business Overview
Table 151. Novartis AG Product
Table 152. Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 153. Novartis AG Recent Development
Table 154. Paratek Pharmaceuticals Inc Company Details
Table 155. Paratek Pharmaceuticals Inc Business Overview
Table 156. Paratek Pharmaceuticals Inc Product
Table 157. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 158. Paratek Pharmaceuticals Inc Recent Development
Table 159. Pfizer Inc Company Details
Table 160. Pfizer Inc Business Overview
Table 161. Pfizer Inc Product
Table 162. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 163. Pfizer Inc Recent Development
Table 164. Phosphagenics Ltd Company Details
Table 165. Phosphagenics Ltd Business Overview
Table 166. Phosphagenics Ltd Product
Table 167. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020) (Million US$)
Table 168. Phosphagenics Ltd Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acne Vulgaris Treatment Market Share by Type: 2020 VS 2026
Figure 2. CB-0601 Features
Figure 3. CJM-112 Features
Figure 4. CLS-007 Features
Figure 5. Dapsone Features
Figure 6. DFD-10 Features
Figure 7. DLX-2323 Features
Figure 8. Others Features
Figure 9. Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Acne Vulgaris Treatment Report Years Considered
Figure 14. Global Acne Vulgaris Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Acne Vulgaris Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Acne Vulgaris Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Acne Vulgaris Treatment Market Share by Players in 2019
Figure 19. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2019
Figure 21. North America Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Acne Vulgaris Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Common Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 30. Cutanea Life Sciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 32. Dermira Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 34. ELORAC Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 36. Ensol Biosciences Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 38. Foamix Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 40. Galderma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 42. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 44. Helix BioMedix Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 46. Hovione FarmaCiencia SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 48. Lee's Pharmaceutical Holdings Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 50. LEO Pharma A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 52. Novabiotics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 54. Novan Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 56. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 58. Paratek Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 60. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 62. Phosphagenics Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs